uniQure N.V.
General ticker "QURE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.0B (TTM average)
uniQure N.V. follows the US Stock Market performance with the rate: 34.6%.
Estimated limits based on current volatility of 1.3%: low 23.22$, high 24.92$
Factors to consider:
- Total employees count: 209 (-56.5%) as of 2024
- Top business risk factors: Intellectual property risks, Insufficient funding, Strategic risks and growth management, Liquidity and credit risks, Labor/talent shortage/retention
- Current price 11.2% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.90$, 20.44$]
- 2025-12-31 to 2026-12-31 estimated range: [5.43$, 14.49$]
Financial Metrics affecting the QURE estimates:
- Negative: with PPE of -3.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -22.08 <= 0.33
- Positive: Inventory ratio change, % of -43.15 <= -0.75
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -1.21 <= 18.93
- Negative: negative Industry operating cash flow (median)
Short-term QURE quotes
Long-term QURE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $106.48MM | $15.84MM | $27.12MM |
| Operating Expenses | $249.64MM | $298.71MM | $211.41MM |
| Operating Income | $-143.16MM | $-282.87MM | $-184.29MM |
| Non-Operating Income | $14.90MM | $-23.69MM | $-52.83MM |
| Interest Expense | $11.70MM | $41.56MM | $63.74MM |
| R&D Expense | $197.59MM | $214.86MM | $143.78MM |
| Income(Loss) | $-128.26MM | $-306.56MM | $-237.13MM |
| Taxes | $-1.47MM | $1.92MM | $2.43MM |
| Profit(Loss)* | $-126.79MM | $-308.48MM | $-239.56MM |
| Stockholders Equity | $476.01MM | $207.67MM | $-6.75MM |
| Inventory | $6.92MM | $12.02MM | $0.00MM |
| Assets | $704.96MM | $831.69MM | $556.54MM |
| Operating Cash Flow | $-145.06MM | $-145.93MM | $-182.73MM |
| Capital expenditure | $17.69MM | $7.15MM | $3.37MM |
| Investing Cash Flow | $-182.73MM | $-205.69MM | $162.97MM |
| Financing Cash Flow | $1.45MM | $362.72MM | $-59.49MM |
| Earnings Per Share** | $-2.71 | $-6.47 | $-4.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.